ATE191850T1 - Eichenrindenextraktverwandte synthetische zubereitungen und verfahren zur verwendung - Google Patents

Eichenrindenextraktverwandte synthetische zubereitungen und verfahren zur verwendung

Info

Publication number
ATE191850T1
ATE191850T1 AT94900557T AT94900557T ATE191850T1 AT E191850 T1 ATE191850 T1 AT E191850T1 AT 94900557 T AT94900557 T AT 94900557T AT 94900557 T AT94900557 T AT 94900557T AT E191850 T1 ATE191850 T1 AT E191850T1
Authority
AT
Austria
Prior art keywords
oak bark
bark extract
ions
methods
extract
Prior art date
Application number
AT94900557T
Other languages
English (en)
Inventor
David N S Hon
R Thomas Stanley
Original Assignee
Greystone Medical Group Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Greystone Medical Group Inc filed Critical Greystone Medical Group Inc
Application granted granted Critical
Publication of ATE191850T1 publication Critical patent/ATE191850T1/de

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • A61K33/04Sulfur, selenium or tellurium; Compounds thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • A61K33/06Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • A61K33/24Heavy metals; Compounds thereof
    • A61K33/30Zinc; Compounds thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/49Fagaceae (Beech family), e.g. oak or chestnut
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/02Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • A61P31/18Antivirals for RNA viruses for HIV
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • A61P35/04Antineoplastic agents specific for metastasis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Inorganic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Microbiology (AREA)
  • Virology (AREA)
  • Mycology (AREA)
  • Medical Informatics (AREA)
  • Oncology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • AIDS & HIV (AREA)
  • Communicable Diseases (AREA)
  • Molecular Biology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Chemical And Physical Treatments For Wood And The Like (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Medicinal Preparation (AREA)
  • Laminated Bodies (AREA)
  • Cosmetics (AREA)
  • Road Paving Structures (AREA)
AT94900557T 1992-11-06 1993-11-04 Eichenrindenextraktverwandte synthetische zubereitungen und verfahren zur verwendung ATE191850T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US97307192A 1992-11-06 1992-11-06
PCT/US1993/010670 WO1994011010A2 (en) 1992-11-06 1993-11-04 Compositions of oak bark extract, related synthetic compositions, and method of using same

Publications (1)

Publication Number Publication Date
ATE191850T1 true ATE191850T1 (de) 2000-05-15

Family

ID=25520460

Family Applications (1)

Application Number Title Priority Date Filing Date
AT94900557T ATE191850T1 (de) 1992-11-06 1993-11-04 Eichenrindenextraktverwandte synthetische zubereitungen und verfahren zur verwendung

Country Status (21)

Country Link
US (1) US6149947A (de)
EP (1) EP0668769B1 (de)
JP (1) JP3640215B2 (de)
AT (1) ATE191850T1 (de)
AU (1) AU700019B2 (de)
BR (1) BR9307401A (de)
CA (1) CA2148795C (de)
CY (1) CY2231B1 (de)
CZ (1) CZ117395A3 (de)
DE (1) DE69328438T2 (de)
DK (1) DK0668769T3 (de)
ES (1) ES2147780T3 (de)
HU (1) HUT73791A (de)
MX (1) MX9306960A (de)
NO (1) NO951740L (de)
NZ (1) NZ258019A (de)
OA (1) OA10153A (de)
PL (1) PL308770A1 (de)
PT (1) PT668769E (de)
WO (1) WO1994011010A2 (de)
ZA (1) ZA938274B (de)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7014870B1 (en) * 1992-11-06 2006-03-21 Greystone Medical Group, Inc. Compositions of oak bark extract related synthetic compositions and method of using same
AUPN104895A0 (en) * 1995-02-10 1995-03-09 Lai, John Methods of and preparations for the treatment of ailments and disorders
US20040037898A1 (en) * 1997-10-08 2004-02-26 Hon David N.S Compositions of oak bark extract, related synthetic compositions and method of using same
RU2125460C1 (ru) * 1997-11-17 1999-01-27 Закрытое акционерное общество научно-производственная фирма "Новь" Биостимулирующее средство
US20050033251A1 (en) * 1998-12-08 2005-02-10 Quick-Med Technologies, Inc. Controlled release of biologically active substances from select substrates
US20040170703A1 (en) * 2001-11-29 2004-09-02 Greystone Medical Group, Inc. Reduction of reactive oxygen species in chronic wound management
AU2002359529B2 (en) * 2001-11-29 2008-02-21 Greystone Medical Group, Inc. Treatment of wounds and compositions employed
US6667026B1 (en) 2002-03-15 2003-12-23 Pocono Falls, Inc. Allergic contact dermatitis treatment and composition therefor
CA2486704A1 (en) * 2002-05-24 2003-12-04 Greystone Medical Group, Inc. Anti-cancer formulation
CA2511440A1 (en) * 2002-12-23 2004-07-15 Greystone Medical Group, Inc. Reduction of reactive oxygen species in chronic wound management
WO2005000328A1 (en) * 2003-06-24 2005-01-06 Zanti Gianfranco Compositions based on plant ash for the treatment of skin diseases
AU2005258225A1 (en) * 2004-06-22 2006-01-05 Greystone Medical Group, Inc. Methods for treatment of wounds using time release compositions
KR101324578B1 (ko) 2006-02-03 2013-11-01 제이알 켐, 엘엘씨 구리 및 아연 조성물을 사용하는 노화 방지 치료법
US7897800B2 (en) 2006-02-03 2011-03-01 Jr Chem, Llc Chemical compositions and methods of making them
US7687650B2 (en) 2006-02-03 2010-03-30 Jr Chem, Llc Chemical compositions and methods of making them
US7867522B2 (en) 2006-09-28 2011-01-11 Jr Chem, Llc Method of wound/burn healing using copper-zinc compositions
EP2173363B1 (de) 2007-03-15 2016-12-07 Om Kataria Gebärmutter-stimulierende stäbchen
US9889151B2 (en) 2007-10-15 2018-02-13 Hs Pharmaceuticals, Llc Silicate containing compositions and methods of treatment
US8273791B2 (en) 2008-01-04 2012-09-25 Jr Chem, Llc Compositions, kits and regimens for the treatment of skin, especially décolletage
CA2750636C (en) 2009-01-23 2017-07-25 Jr Chem, Llc Rosacea treatments and kits for performing them
WO2011103158A1 (en) * 2010-02-16 2011-08-25 Michael Darryl Black Systems and methods that kill infectious agents (bacteria) without the use of a systemic anti-biotic
US8952057B2 (en) 2011-01-11 2015-02-10 Jr Chem, Llc Compositions for anorectal use and methods for treating anorectal disorders
US8828449B2 (en) 2012-01-26 2014-09-09 Libby Robinson Wound dressing composition and method of use
US9351995B1 (en) 2011-04-29 2016-05-31 Red Oax Holdings, LLC Compositions and methods of enhancing wound healing
EP2734243A1 (de) * 2011-07-20 2014-05-28 3M Innovative Properties Company Verband mit ionenträgerzusammensetzung
JP6133858B2 (ja) * 2011-07-28 2017-05-24 スリーエム イノベイティブ プロパティズ カンパニー 創傷治癒組成物及び使用方法
JP6697842B2 (ja) 2011-08-17 2020-05-27 スリーエム イノベイティブ プロパティズ カンパニー モノマーグラフト化繊維及びその使用
GB201402672D0 (en) 2014-02-14 2014-04-02 Medical Res Council Materials and methods relating to stabilised polymeric silicate compositions
US10500235B2 (en) 2015-01-29 2019-12-10 San Melix Laboratories, Inc. Wound healing compositions comprising buckwheat honey and methylglyoxal and methods of use
SG11202109537WA (en) * 2019-03-04 2021-09-29 Celloryx AG Chloride-inducible prokaryotic expression system
IT201900018047A1 (it) * 2019-10-07 2021-04-07 Nello Vallicella Procedimento per la preparazione di una composizione topica liquida.
WO2024196897A1 (en) * 2023-03-22 2024-09-26 Courtland Imel Novel methods for increasing healing speed of human and animal wounds

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US202246A (en) * 1878-04-09 Improvement in medical compounds
US256847A (en) * 1882-04-25 Salve
US55911A (en) * 1866-06-26 Improved medical compound
US37901A (en) * 1863-03-17 Improved liniment
DE819127C (de) * 1949-09-28 1951-10-29 Heinz Dr Bauer Verfahren zur Herstellung eines Heilbades gegen Hautekzeme
DE812341C (de) * 1950-03-07 1951-08-27 Penicillin Ges Dauelsberg & Co Verfahren zur Herstellung eines Hautbehandlungsmittels
DE833840C (de) * 1950-06-01 1952-03-13 Dr Heinz Bauer Verfahren zur Herstellung einer Salbe gegen Hautekzeme
US3928584A (en) * 1969-06-30 1975-12-23 Us Health Education & Welfare Extracts from active tree saps for treating P388 mouse leukemia
US4059695A (en) * 1974-02-14 1977-11-22 Kanari Hirosaki Method for manufacturing a tonic composition for man and other animals
JPS60164467A (ja) * 1984-02-07 1985-08-27 Rooman Kogyo:Kk 飲料
ATE69954T1 (de) * 1985-10-08 1991-12-15 Psori Med Ag Salzmischung zur behandlung der schuppenflechte (psoriasis) und anderer hautkrankheiten.
US4847083A (en) * 1986-04-02 1989-07-11 Dermasciences, Inc. Two-step procedure for indolent wound healing and aqueous medium and topical ointment used in connection therewith
BE1000950A3 (fr) * 1987-10-05 1989-05-23 Claude Patricia Produit de beaute saliaris au sel de la mer morte et a l'argile verte de haute provence.
AT393221B (de) * 1988-02-03 1991-09-10 Leopold Pharma Gmbh Mittel mit zerstoerender wirkung auf maligne tumore, verfahren zu dessen herstellung und praeparation zur anwendung in der therapie von krebskranken
US5080900A (en) * 1990-04-17 1992-01-14 Stanley R Thomas Treatment of skin ulcers with an aqueous extract of oak bark ash

Also Published As

Publication number Publication date
CY2231B1 (en) 2003-04-18
DE69328438D1 (de) 2000-05-25
PL308770A1 (en) 1995-08-21
WO1994011010A3 (en) 1994-09-15
US6149947A (en) 2000-11-21
HUT73791A (en) 1996-09-30
ZA938274B (en) 1994-06-09
NZ258019A (en) 1998-12-23
NO951740D0 (no) 1995-05-04
MX9306960A (es) 1995-01-31
JP3640215B2 (ja) 2005-04-20
EP0668769B1 (de) 2000-04-19
DK0668769T3 (da) 2000-10-02
ES2147780T3 (es) 2000-10-01
BR9307401A (pt) 1999-08-24
AU700019B2 (en) 1998-12-17
CA2148795A1 (en) 1994-05-26
CA2148795C (en) 2004-08-10
PT668769E (pt) 2000-10-31
DE69328438T2 (de) 2001-01-04
CZ117395A3 (en) 1995-11-15
HU9501323D0 (en) 1996-05-28
NO951740L (no) 1995-06-19
EP0668769A1 (de) 1995-08-30
WO1994011010A2 (en) 1994-05-26
AU5550094A (en) 1994-06-08
JPH08503462A (ja) 1996-04-16
OA10153A (en) 1996-12-18

Similar Documents

Publication Publication Date Title
ATE191850T1 (de) Eichenrindenextraktverwandte synthetische zubereitungen und verfahren zur verwendung
DE10199020I2 (de) Galanthamin oder dessen Analoge zur Behandlung derAlzheimerschen Krankheit.
DE69631478D1 (de) Verwendung von vitamin d4-derivaten zur behandlung von hauterkrankungen
ES2033434T3 (es) Composicion cosmetica.
WO1994011010B1 (en) Compositions of oak bark extract, related synthetic compositions, and method of using same
ATE233558T1 (de) Verwendung von strontiumsälze zur behandlung von arthrose
DE59601880D1 (de) Verfahren zur herstellung hydrophiler oder teilweise hydrophiler, anorganischer aerogele
DE69132048D1 (de) Verwendung von Steroiden zur Inhibierung von Angiogenesis
AU6998787A (en) Transglutaminase inhibitors
ATE225340T1 (de) Einschlusskomplexe von taxol oder taxotere oder taxus-extrakten und cyclodextrinen, ihre herstellung und ihre verwendung
DE69130497D1 (de) Neue Verwendung von 1-Alpha-hydroxylierten-19-nor-vitamin-D-Verbindungen zur Behandlung von Psoriasis
ATE83378T1 (de) Verwendung von 3'-azido-deoxythymidin zur herstellung eines arzneimittels zur behandlung von humanen brustcarzinomen.
ATE179594T1 (de) Verwendung von ethisterone zur topischen behandlung von akne oder androgenetischer alopezie
ATE136465T1 (de) Verwendung von gibberellinen zur herstellung eines arzneimittels zur behandlung von prostatitis
ATE42466T1 (de) Verwendung von saccharomyces hefen zur herstellung eines medikaments zur verhuetung oder behandlung von pseudomembrankolitis.
ES2076141T3 (es) 5-aril-3h-1,2,4-triazol-3-onas y su uso como anticonvulsivos.
DE59900286D1 (de) Verwendung von sphingosin-1-phosphat, sphingosin-1-phosphat-derivaten und/oder deren gemische zur behandlung von entzündlichen hautkrankheiten
DE69232852D1 (de) Verwendung von topotecan in der behandlung von nichtkleinzelligen lungenkarzinomen
DE3775278D1 (de) Topische methotrexatzubereitung zur behandlung hyperproliferativer epithelerkrankungen.
ATE178336T1 (de) Verwendung einer therapeutischen zusammensetzung zur behandlung von bronchitis
ATE107166T1 (de) Verwendung von chlormethiazol zur herstellung eines artzneimittels zur prophylaxe oder therapie der neurodegeneration.
IT8547778A1 (it) Agenti stimolanti la crescita dei capelli e loro impiego
GB8428552D0 (en) Organic compounds
IT8619957A0 (it) Composizione profumata per il trattamento di articoli in pelle e cuoio.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee